Achieve Life Sciences Inc...

NASDAQ: ACHV · Real-Time Price · USD
2.56
0.01 (0.39%)
At close: Aug 15, 2025, 3:48 PM

Achieve Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 228K 236K 250K
Gross Profit
n/a -228K -236K -250K
Operating Income
-39.07M -27.25M -40.8M -33.09M
Interest Income
2.36M 825K 199K 17K
Pretax Income
-39.83M -29.82M -42.35M -33.15M
Net Income
-39.83M -29.82M -41.88M -32.9M
Selling & General & Admin
16.25M 11.44M 10.72M 9.13M
Research & Development
22.82M 15.81M 30.08M 23.97M
Other Expenses
n/a n/a n/a -58K
Operating Expenses
39.07M 27.02M 40.8M 33.09M
Interest Expense
2.18M 2.85M 1.79M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 27.25M 40.8M 33.09M
Income Tax Expense
n/a n/a -475K -250K
Shares Outstanding (Basic)
32.07M 19.83M 10.59M 8.12M
Shares Outstanding (Diluted)
32.07M 19.83M 10.59M 8.12M
EPS (Basic)
-1.24 -1.5 -3.95 -4.05
EPS (Diluted)
-1.24 -1.5 -3.95 -4.05
EBITDA
-37.42M -26.73M -40.33M -32.9M
EBIT
-37.65M -26.96M -40.56M -33.15M
Depreciation & Amortization
229K 228K 236K 250K